252 related articles for article (PubMed ID: 24494586)
1. Alternative splice forms of CTLA-4 induced by antisense mediated splice-switching influences autoimmune diabetes susceptibility in NOD mice.
Mourich DV; Oda SK; Schnell FJ; Crumley SL; Hauck LL; Moentenich CA; Marshall NB; Hinrichs DJ; Iversen PL
Nucleic Acid Ther; 2014 Apr; 24(2):114-26. PubMed ID: 24494586
[TBL] [Abstract][Full Text] [Related]
2. The B7-independent isoform of CTLA-4 functions to regulate autoimmune diabetes.
Stumpf M; Zhou X; Bluestone JA
J Immunol; 2013 Feb; 190(3):961-9. PubMed ID: 23293354
[TBL] [Abstract][Full Text] [Related]
3. Genetic evidence that the differential expression of the ligand-independent isoform of CTLA-4 is the molecular basis of the Idd5.1 type 1 diabetes region in nonobese diabetic mice.
Araki M; Chung D; Liu S; Rainbow DB; Chamberlain G; Garner V; Hunter KM; Vijayakrishnan L; Peterson LB; Oukka M; Sharpe AH; Sobel R; Kuchroo VK; Wicker LS
J Immunol; 2009 Oct; 183(8):5146-57. PubMed ID: 19783679
[TBL] [Abstract][Full Text] [Related]
4. Immunoinhibitory DNA vaccine protects against autoimmune diabetes through cDNA encoding a selective CTLA-4 (CD152) ligand.
Prud'homme GJ; Chang Y; Li X
Hum Gene Ther; 2002 Feb; 13(3):395-406. PubMed ID: 11860706
[TBL] [Abstract][Full Text] [Related]
5. An autoimmune disease-associated CTLA-4 splice variant lacking the B7 binding domain signals negatively in T cells.
Vijayakrishnan L; Slavik JM; Illés Z; Greenwald RJ; Rainbow D; Greve B; Peterson LB; Hafler DA; Freeman GJ; Sharpe AH; Wicker LS; Kuchroo VK
Immunity; 2004 May; 20(5):563-75. PubMed ID: 15142525
[TBL] [Abstract][Full Text] [Related]
6. The soluble CTLA-4 splice variant protects from type 1 diabetes and potentiates regulatory T-cell function.
Gerold KD; Zheng P; Rainbow DB; Zernecke A; Wicker LS; Kissler S
Diabetes; 2011 Jul; 60(7):1955-63. PubMed ID: 21602513
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of T cell activation and autoimmune diabetes using a B cell surface-linked CTLA-4 agonist.
Fife BT; Griffin MD; Abbas AK; Locksley RM; Bluestone JA
J Clin Invest; 2006 Aug; 116(8):2252-61. PubMed ID: 16886063
[TBL] [Abstract][Full Text] [Related]
8. A SNP in the Immunoregulatory Molecule CTLA-4 Controls mRNA Splicing In Vivo but Does Not Alter Diabetes Susceptibility in the NOD Mouse.
Jakubczik F; Jones K; Nichols J; Mansfield W; Cooke A; Holmes N
Diabetes; 2016 Jan; 65(1):120-8. PubMed ID: 26450994
[TBL] [Abstract][Full Text] [Related]
9. Induction of tolerance in murine autoimmune diabetes by transient blockade of leukocyte function-associated antigen-1/intercellular adhesion molecule-1 pathway.
Moriyama H; Yokono K; Amano K; Nagata M; Hasegawa Y; Okamoto N; Tsukamoto K; Miki M; Yoneda R; Yagi N; Tominaga Y; Kikutani H; Hioki K; Okumura K; Yagita H; Kasuga M
J Immunol; 1996 Oct; 157(8):3737-43. PubMed ID: 8871677
[TBL] [Abstract][Full Text] [Related]
10. Cytotoxic T lymphocyte antigen 4 (CD152) regulates self-reactive T cells in BALB/c but not in the autoimmune NOD mouse.
Piganelli JD; Poulin M; Martin T; Allison JP; Haskins K
J Autoimmun; 2000 Mar; 14(2):123-31. PubMed ID: 10677243
[TBL] [Abstract][Full Text] [Related]
11. Low expression and secretion of circulating soluble CTLA-4 in peripheral blood mononuclear cells and sera from type 1 diabetic children.
Rydén A; Bolmeson C; Jonson CO; Cilio CM; Faresjö M
Diabetes Metab Res Rev; 2012 Jan; 28(1):84-96. PubMed ID: 22218756
[TBL] [Abstract][Full Text] [Related]
12. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease.
Ueda H; Howson JM; Esposito L; Heward J; Snook H; Chamberlain G; Rainbow DB; Hunter KM; Smith AN; Di Genova G; Herr MH; Dahlman I; Payne F; Smyth D; Lowe C; Twells RC; Howlett S; Healy B; Nutland S; Rance HE; Everett V; Smink LJ; Lam AC; Cordell HJ; Walker NM; Bordin C; Hulme J; Motzo C; Cucca F; Hess JF; Metzker ML; Rogers J; Gregory S; Allahabadia A; Nithiyananthan R; Tuomilehto-Wolf E; Tuomilehto J; Bingley P; Gillespie KM; Undlien DE; Rønningen KS; Guja C; Ionescu-Tîrgovişte C; Savage DA; Maxwell AP; Carson DJ; Patterson CC; Franklyn JA; Clayton DG; Peterson LB; Wicker LS; Todd JA; Gough SC
Nature; 2003 May; 423(6939):506-11. PubMed ID: 12724780
[TBL] [Abstract][Full Text] [Related]
13. An autoimmune disease-associated CTLA4 splice variant lacking the B7 binding domain signals negatively in T cells.
Vijayakrishnan L; Slavik JM; Illés Z; Rainbow D; Peterson LB; Sharpe AS; Wicker LS; Kuchroo VK
Novartis Found Symp; 2005; 267():200-12; discussion 212-8. PubMed ID: 15999808
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of the Ctla-4 isoform lacking exons 2 and 3 causes autoimmunity.
Liu SM; Sutherland AP; Zhang Z; Rainbow DB; Quintana FJ; Paterson AM; Sharpe AH; Oukka M; Wicker LS; Kuchroo VK
J Immunol; 2012 Jan; 188(1):155-62. PubMed ID: 22124121
[TBL] [Abstract][Full Text] [Related]
15. Protective regulatory T cell generation in autoimmune diabetes by DNA covaccination with islet antigens and a selective CTLA-4 ligand.
Glinka Y; Chang Y; Prud'homme GJ
Mol Ther; 2006 Oct; 14(4):578-87. PubMed ID: 16790365
[TBL] [Abstract][Full Text] [Related]
16. Thymic epithelium determines a spontaneous chronic neuritis in Icam1(tm1Jcgr)NOD mice.
Meyer zu Horste G; Mausberg AK; Cordes S; El-Haddad H; Partke HJ; Leussink VI; Roden M; Martin S; Steinman L; Hartung HP; Kieseier BC
J Immunol; 2014 Sep; 193(6):2678-90. PubMed ID: 25108020
[TBL] [Abstract][Full Text] [Related]
17. The soluble CTLA-4 receptor: a new marker in autoimmune diseases.
Pawlak E; Kochanowska IE; Frydecka I; Kiełbiński M; Potoczek S; Bilińska M
Arch Immunol Ther Exp (Warsz); 2005; 53(4):336-41. PubMed ID: 16088318
[TBL] [Abstract][Full Text] [Related]
18. Autoimmune diabetes-prone NOD mice express the Lyt2 alpha (Lyt2.1) and Lyt3 alpha (Lyt3.1) alleles of CD8.
Johnson-Tardieu JM; Walworth EW; Cornelius JG; Ye X; Schuster SM; Peck AB
Immunogenetics; 1996; 43(1-2):6-12. PubMed ID: 8537123
[TBL] [Abstract][Full Text] [Related]
19. Costimulation controls diabetes by altering the balance of pathogenic and regulatory T cells.
Bour-Jordan H; Salomon BL; Thompson HL; Szot GL; Bernhard MR; Bluestone JA
J Clin Invest; 2004 Oct; 114(7):979-87. PubMed ID: 15467837
[TBL] [Abstract][Full Text] [Related]
20. Collagen-induced arthritis in the BB rat. Prevention of disease by treatment with CTLA-4-Ig.
Knoerzer DB; Karr RW; Schwartz BD; Mengle-Gaw LJ
J Clin Invest; 1995 Aug; 96(2):987-93. PubMed ID: 7543497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
